• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物紊乱与慢性肾脏病的蛋白质能量消耗:叙述性综述。

Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: a narrative review.

机构信息

Unidad de Investigación Médica en Enfermedades Renales, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social, Guadalajara, Jalisco, Mexico.

Division of Renal Medicine and Baxter Novum, Department of Clinical Science, Technology and Intervention, Karolinska Institutet, M99 Karolinska University Hospital Huddinge, 14186, Stockholm, Sweden.

出版信息

J Nephrol. 2023 Apr;36(3):873-883. doi: 10.1007/s40620-022-01560-1. Epub 2023 Jan 23.

DOI:10.1007/s40620-022-01560-1
PMID:36689170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9869315/
Abstract

Protein-energy wasting (PEW) is common in patients with chronic kidney disease (CKD) and is associated with increased morbidity and mortality, and lower quality of life. It is a complex syndrome, in which inflammation and retention of uremic toxins are two main factors. Causes of inflammation and uremic toxin retention in CKD are multiple; however, gut dysbiosis plays an important role, serving as a link between those entities and PEW. Besides, there are several pathways by which microbiota may influence PEW, e.g., through effects on appetite mediated by microbiota-derived proteins and hormonal changes, or by impacting skeletal muscle via a gut-muscle axis. Hence, microbiota disturbances may influence PEW independently of its relationship with local and systemic inflammation. A better understanding of the complex interrelationships between microbiota and the host may help to explain how changes in the gut affect distant organs and systems of the body and could potentially lead to the development of new strategies targeting the microbiota to improve nutrition and clinical outcomes in CKD patients. In this review, we describe possible interactions of gut microbiota with nutrient metabolism, energy balance, hunger/satiety signals and muscle depletion, all of which are strongly related to PEW in CKD patients.

摘要

蛋白质能量消耗(PEW)在慢性肾脏病(CKD)患者中很常见,与发病率和死亡率增加以及生活质量降低有关。它是一种复杂的综合征,其中炎症和尿毒症毒素的潴留是两个主要因素。CKD 中炎症和尿毒症毒素潴留的原因很多;然而,肠道菌群失调起着重要作用,是这些实体与 PEW 之间的联系。此外,微生物群可能通过多种途径影响 PEW,例如,通过微生物群衍生蛋白对食欲的影响和激素变化,或通过肠道-肌肉轴影响骨骼肌。因此,微生物群的紊乱可能独立于其与局部和全身炎症的关系而影响 PEW。更好地理解微生物群和宿主之间的复杂相互关系,可以帮助解释肠道的变化如何影响身体的远处器官和系统,并可能导致针对微生物群的新策略的发展,以改善 CKD 患者的营养和临床结局。在这篇综述中,我们描述了肠道微生物群与营养代谢、能量平衡、饥饿/饱腹感信号和肌肉消耗之间可能的相互作用,所有这些都与 CKD 患者的 PEW 密切相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/10090005/6aca4270520b/40620_2022_1560_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/10090005/6aca4270520b/40620_2022_1560_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b755/10090005/6aca4270520b/40620_2022_1560_Fig1_HTML.jpg

相似文献

1
Gut microbiota disturbances and protein-energy wasting in chronic kidney disease: a narrative review.肠道微生物紊乱与慢性肾脏病的蛋白质能量消耗:叙述性综述。
J Nephrol. 2023 Apr;36(3):873-883. doi: 10.1007/s40620-022-01560-1. Epub 2023 Jan 23.
2
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.慢性肾脏病患者的合生菌、益生元和益生菌。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2.
3
Kidney-Gut Axis in Chronic Kidney Disease: Therapeutic Perspectives from Microbiota Modulation and Nutrition.慢性肾脏病中的肾-肠轴:微生物群调节与营养的治疗前景
Nutrients. 2025 Jun 9;17(12):1961. doi: 10.3390/nu17121961.
4
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.固体器官移植受者的共生元、益生元和益生菌。
Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2.
5
Impact of Gut Microbiome Modulation on Uremic Toxin Reduction in Chronic Kidney Disease: A Systematic Review and Network Meta-Analysis.肠道微生物群调节对慢性肾脏病患者尿毒症毒素降低的影响:一项系统评价和网状Meta分析
Nutrients. 2025 Apr 3;17(7):1247. doi: 10.3390/nu17071247.
6
Interventions for chronic kidney disease-associated restless legs syndrome.慢性肾脏病相关不宁腿综合征的干预措施。
Cochrane Database Syst Rev. 2016 Nov 7;11(11):CD010690. doi: 10.1002/14651858.CD010690.pub2.
7
Intestinal inflammation and microbiota modulation impact cochlear function: emerging insights in gut-ear axis.肠道炎症与微生物群调节影响耳蜗功能:肠道-耳轴的新见解
Cell Commun Signal. 2025 Jul 26;23(1):357. doi: 10.1186/s12964-025-02338-1.
8
Dietary Intake and Gut Microbiome in CKD.慢性肾脏病中的饮食摄入与肠道微生物群
Clin J Am Soc Nephrol. 2025 Mar 11;20(7):1003-1013. doi: 10.2215/CJN.0000000705.
9
[Risk factors analysis of protein energy wasting in children with chronic kidney disease].[慢性肾脏病患儿蛋白质能量消耗的危险因素分析]
Zhonghua Er Ke Za Zhi. 2023 Sep 2;61(9):794-798. doi: 10.3760/cma.j.cn112140-20230502-00309.
10
Body cell mass estimation by whole body potassium counter and its association with protein energy wasting in Indian children with chronic kidney disease.通过全身钾计数器估算身体细胞质量及其与印度慢性肾病儿童蛋白质能量消耗的关联。
Pediatr Nephrol. 2025 Aug;40(8):2619-2626. doi: 10.1007/s00467-025-06739-9. Epub 2025 Mar 17.

引用本文的文献

1
Microbiota-friendly diet ameliorates hypoalbuminemia in chronic kidney disease: evidence from NHANES.微生物群友好型饮食改善慢性肾脏病患者的低白蛋白血症:来自美国国家健康与营养检查调查(NHANES)的证据。
Front Immunol. 2025 May 6;16:1546031. doi: 10.3389/fimmu.2025.1546031. eCollection 2025.
2
Chrononutrition in Chronic Kidney Disease.慢性肾脏病中的时间营养学
Nutrients. 2025 Jan 22;17(3):389. doi: 10.3390/nu17030389.
3
The gut microbiome, chronic kidney disease, and sarcopenia.肠道微生物组、慢性肾脏病和肌肉减少症。

本文引用的文献

1
The role of NLRP3 inflammasome in inflammation-related skeletal muscle atrophy.NLRP3 炎性小体在炎症相关的骨骼肌萎缩中的作用。
Front Immunol. 2022 Nov 3;13:1035709. doi: 10.3389/fimmu.2022.1035709. eCollection 2022.
2
Glomerular hyperfiltration in morbid obesity: Role of the inflammasome signalling.病态肥胖中的肾小球高滤过:炎性小体信号传导的作用。
Nephrology (Carlton). 2022 Aug;27(8):673-680. doi: 10.1111/nep.14077. Epub 2022 Jun 26.
3
The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses.
Cell Commun Signal. 2024 Nov 21;22(1):558. doi: 10.1186/s12964-024-01922-1.
4
Phase angle is a useful predicting indicator for protein-energy wasting and cardiovascular risk among maintenance hemodialysis patients.相位角是维持性血液透析患者蛋白质能量消耗和心血管风险的有用预测指标。
Sci Rep. 2024 Nov 15;14(1):28151. doi: 10.1038/s41598-024-78957-4.
5
Gut Microbiota in Patients Receiving Dialysis: A Review.接受透析患者的肠道微生物群:综述
Pathogens. 2024 Sep 15;13(9):801. doi: 10.3390/pathogens13090801.
6
External validation of a novel nomogram for diagnosis of Protein Energy Wasting in adult hemodialysis patients.一种用于诊断成年血液透析患者蛋白质能量消耗的新型列线图的外部验证
Front Nutr. 2024 Aug 13;11:1351503. doi: 10.3389/fnut.2024.1351503. eCollection 2024.
7
Exploring the Relationship between Gut Microbiome Composition and Blood Indole-3-acetic Acid in Hemodialysis Patients.探索血液透析患者肠道微生物群组成与血液中吲哚 - 3 - 乙酸之间的关系。
Biomedicines. 2024 Jan 10;12(1):148. doi: 10.3390/biomedicines12010148.
8
An Overview of Chronic Kidney Disease Pathophysiology: The Impact of Gut Dysbiosis and Oral Disease.慢性肾脏病病理生理学概述:肠道微生物群失调与口腔疾病的影响
Biomedicines. 2023 Nov 12;11(11):3033. doi: 10.3390/biomedicines11113033.
9
Biotics (Pre-, Pro-, Post-) and Uremic Toxicity: Implications, Mechanisms, and Possible Therapies.生物制剂(前、中、后)与尿毒症毒素:影响、机制及可能的治疗方法。
Toxins (Basel). 2023 Sep 4;15(9):548. doi: 10.3390/toxins15090548.
10
The Usefulness of Resistant Maltodextrin and Chitosan Oligosaccharide in Management of Gut Leakage and Microbiota in Chronic Kidney Disease.抗性麦芽糊精和壳寡糖在慢性肾脏病肠道渗漏和微生物群管理中的作用
Nutrients. 2023 Jul 28;15(15):3363. doi: 10.3390/nu15153363.
血液透析和腹膜透析对终末期肾病患者肠道微生物群的影响以及肠道微生物群与患者预后的关系。
Front Cell Infect Microbiol. 2021 Mar 23;11:579386. doi: 10.3389/fcimb.2021.579386. eCollection 2021.
4
Effects of Probiotics on Malnutrition and Health-Related Quality of Life in Patients Undergoing Peritoneal Dialysis: A Randomized Controlled Trial.益生菌对腹膜透析患者营养不良及健康相关生活质量的影响:一项随机对照试验。
J Ren Nutr. 2021 Mar;31(2):199-205. doi: 10.1053/j.jrn.2020.04.008. Epub 2020 Jun 30.
5
Gut microbiota and Covid-19- possible link and implications.肠道微生物群与新冠病毒(COVID-19):可能的联系及影响。
Virus Res. 2020 Aug;285:198018. doi: 10.1016/j.virusres.2020.198018. Epub 2020 May 13.
6
Association of subjective global assessment of nutritional status with gut microbiota in hemodialysis patients: a case-control study.主观整体评估营养状况与血液透析患者肠道微生物群的关联:一项病例对照研究。
Nephrol Dial Transplant. 2021 May 27;36(6):1104-1111. doi: 10.1093/ndt/gfaa019.
7
High-throughput sequencing analysis of intestinal flora changes in ESRD and CKD patients.高通量测序分析终末期肾病和慢性肾脏病患者肠道菌群变化。
BMC Nephrol. 2020 Jan 13;21(1):12. doi: 10.1186/s12882-019-1668-4.
8
Phosphate Binders and Nonphosphate Effects in the Gastrointestinal Tract.胃肠道中的磷结合剂及非磷效应
J Ren Nutr. 2020 Jan;30(1):4-10. doi: 10.1053/j.jrn.2019.01.004. Epub 2019 Mar 4.
9
Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease.可能影响慢性肾脏病肠道菌群紊乱的饮食成分。
Nutrients. 2019 Feb 27;11(3):496. doi: 10.3390/nu11030496.
10
Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease.肠道微生物群失调对慢性肾脏病神经激素途径的影响
Diseases. 2019 Feb 13;7(1):21. doi: 10.3390/diseases7010021.